TAG:
omnyx
Fujifilm Buys Inspirata’s Digital Pathology Assets
By Robert Michel | From the Volume XXX No. 3 – February 13, 2023 Issue
CEO SUMMARY: Fujifilm’s acquisition of the digital pathology technologies and clients of Inspirata marks the departure of one early entrant into the digital pathology market. At the same time, executives from Fujifilm Healthcare Americas Corporation discuss why the company is incr…
GE Healthcare Sells Omnyx to Inspirata
By Joseph Burns | From the Volume XXV No. 3 – February 12, 2018 Issue
CEO SUMMARY: Now that the FDA has cleared a digital pathology for use in primary diagnosis, interest in DP is building. Inspirata purchased Omnyx and its assets because the Omnyx Dynamyx digital pathology software has strong features that could be integrated into Inspirata’s digital pat…
GE, UPMC Ending Omnyx, Their Digital Pathology Joint Venture
By Robert Michel | From the Volume XXIII No. 11 – August 15, 2016 Issue
IN RECENT WEEKS, pathology laboratory clients of the Omnyx digital pathology system learned that the joint venture is ending. Company officials tell these customers that their digital pathology systems will continue to receive service. Omnyx was formed in 2008 as a joint venture bet…
New Company Ready to Heat Up Slow Digital Pathology Market
By Robert Michel | From the Volume XXII No. 11 – August 3, 2015 Issue
CEO SUMMARY: There’s a new competitor in the digital pathology marketplace with ambitious plans to deliver a fully-integrated pathologist workflow solution. Inspirata, Inc., of Tampa, Florida, made its debut in March at an international pathology conference. In this exclusive i…
February 3, 2014 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XXI No. 2 – February 3, 2014 Issue
Last month, it was announced that Solstas Lab Partners of Greensboro, North Carolina, had agreed to be sold to Quest Diagnostics Incorporated. The sales price is $570 million and financial analysts on Wall Street estimate that the annual revenue at Solstas Lab Partne…
January 13, 2014 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XXI No. 1 – January 13, 2014 Issue
Currently there are 119 operational health information exchanges (HIEs) in the United States. This number is 58% greater than the 75 HIEs that were operational in 2010. These numbers were reported in Health Affairs. The study was authored by researchers at the University of Michigan. Th…
October 21, 2013 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XX No.14 – October 21, 2013 Issue
There is progress on the integration of digital pathology systems and proprietary algorithms designed to help pathologists make diagnoses. This month, Visiopharm and Omnyx LLC, announced a joint venture. On its own, in Europe last year, Visiopharm earned a CE mark fo…
Why Toronto Is Site of Global Digital Path Center
By Robert Michel | From the Volume XVIII No. 7 – May 23, 2011 Issue
CEO SUMMARY: GE Healthcare and Omnyx chose Canada to be the location of their new Global Pathology Innovation Centre of Excellence (PICOE). PICOE’s mission is to demonstrate that digital pathology can improve patient outcomes in a cost-effective manner. GE and Omnyx will use PI…
February 7, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 2 – February 7, 2011 Issue
In Nigeria, the kidnap of a professor of pathology at the University of Uyno last month caused work stoppages by academic union members in protest of the government’s failure to protect medical faculty from the recent rash of kidnappings. Pathologist Dr. Memfin Ekp…
Our Top Ten Lab Stories Highlight Major Changes
By Robert Michel | From the Volume XVII No. 17 – December 6, 2010 Issue
CEO SUMMARY: What makes 2010 a watershed year for the laboratory testing industry is enactment of the 2,700-page Patient Protection and Affordable Care Act (PPACA). Even if parts of this bill are repealed, the remaining parts of the massive legislation will trigger major changes …
CURRENT ISSUE

Volume XXX, No. 13 – September 11, 2023
Recent court rulings involving the No Surprises Act are putting the government on the defensive about provisions of the law. Also, the continued consolidation of the IVD and national laboratory company markets has brought more influence to those lab companies. In addition, learn how clinical labs can earn money from their diagnostic data by helping private insurers navigate Medicare Advantage’s risk adjustment model.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized
The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: customerservice@darkintelligencegroup.com
© 2022 The Dark Report. All rights reserved.